Dyspnea

AACN Advanced Critical Care

Volumn 22, Issue 3, 2011, Pages 257-264

  Campbell, Margaret L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

assessment; critical care; dyspnea; treatment

Indexed keywords

ARTICLE; COGNITIVE DEFECT; DYSPNEA; EVIDENCE BASED NURSING; HUMAN; NURSING; NURSING ASSESSMENT; PREVALENCE;

COGNITION DISORDERS; DYSPNEA; EVIDENCE-BASED NURSING; HUMANS; NURSING ASSESSMENT; PREVALENCE;

EID: 80051743915     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e318220bc4d     Document Type: Article

References (48)

1. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159(1):321-340.
2. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145:467-470.
3. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J. 1994;7:725-729. (Pubitemid 24122970)
4. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin. 2004;20(3):403-417. (Pubitemid 38748483)
5. Solano J P, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58-69. (Pubitemid 43143299)
6. Delgado-Guay MO, Parsons HA, Li Z, Palmer LJ, Bruera E. Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer. 2009;115(2):437-445.
7. Li D T, Puntillo K. A pilot study on coexisting symptoms in intensive care patients. Appl Nurs Res. 2006;19(4):216-219. (Pubitemid 44693186)
8. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001;29(2):277-282. (Pubitemid 32171771)
9. Kress J P, Hall JB. Delirium and sedation. Crit Care Clin. 2004;20(4):419-434.
10. Moosavi SH, Golestanian E, Binks A P, Lansing RW, Brown R, Banzett RB. Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans. J Appl Physiol. 2003;94:141-154. (Pubitemid 36014306)
11. Dean JB, Mulkey DK, Garcia AJ, Putnam RW, Henderson RA. Neuronal sensitivity to hyperoxia, hypercapnia, and inert gases at hyperbaric pressures. J Appl Physiol. 2003;95:883-909. (Pubitemid 37033981)
12. Incalzi RA, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease: a neuropsychological and SPECT study. J Neurol. 2003;250:325-332. (Pubitemid 36399273)
13. Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med. 2004;98(4):351-356. (Pubitemid 38443695)
14. Hung WW, Wisnivesky J P, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(2):134-137.
15. McCloskey DI. Corollary discharges: motor commands and perception. In: Brookhart JM, Mountcastle VB, eds. The Nervous System: Handbook of Physiology. Bethseda, MD: American Physiological Society; 1981:1415-1447.
16. Gandevia SC, Killian KJ, Campbell EJM. The effect of respiratory muscle fatigue on respiratory sensations. Clin Sci. 1981;60:463-466. (Pubitemid 11123454)
17. Redline S, Gottfried SB, Altose MD. Effect of changes in inspiratory muscle strength on the sensation of respiratory force. J Appl Physiol. 1991;70:240-245.
18. Manning HL, Schwartzstein RM. Mechanisms of dyspnea. In: Mahler DA, ed. Dyspnea. New York: Marcel Decker Inc; 1998:63-95.
19. Killian KJ, Gandevia SC, Summers E, Campbell EJM. Effect of increased lung volume on perception of breathlessness, effort, and tension. J Appl Physiol. 1984;57:686-691. (Pubitemid 14048784)
20. El-Manshawi A, Killian KJ, Summers E, Jones NL. Breathlessness during exercise with and without resistive loading. J Appl Physiol. 1986;61(3):896-905. (Pubitemid 16033335)
21. Adams L, Lane R, Shea SA, Cockcroft A, Guz A. Breathlessness during different forms of ventilatory stimulation: a study of mechanisms in normal subjects and respiratory patients. Clin Sci. 1985;69:663-672. (Pubitemid 16235531)
22. 2 in mechanically ventilated quadriplegics. Respir Physiol. 1989;76:53-68. (Pubitemid 19128320)
23. Banzett RB, Lansing RW, Evans KC, Shea SA. Stimulusresponse characteristics of CO2-induced air hunger in normal subjects. Respir Physiol. 1996;103:19-31.
24. Russell WC, Greer JR. The comfort of breathing: a study with volunteers assessing the influence of various modes of assisted ventilation. Crit Care Med. 2000;28(11):3645-3648.
25. Campbell ML. Fear and pulmonary stress behaviors to an asphyxial threat across cognitive states. Res Nurs Health. 2007;30(6):572-583.
26. Gift AG. Clinical measurement of dyspnea. Dimens Crit Care Nurs. 1989;8(4):210-216.
27. Carrieri-Kohlman V, Stulbarg M. Dyspnea. In: Carrieri-Kohlman V, Lindsey AM, West CM, eds. Pathophysiological Phenomena in Nursing. 3rd ed. St Louis, MO: Saunders; 2003:175-207.
28. Radbruch L, Sabatowski R, Loick G, et al. Cognitive impairment and its influence on pain and symptom assessment in a palliative care unit: development of a Minimal Documentation System. Palliat Med. 2000;14:266-276. (Pubitemid 30609545)
29. Campbell ML, Templin T, Walch J. Patients who are near death are frequently unable to self-report dyspnea. J Palliat Med. 2009;12(10):881-884.
30. Campbell ML. Respiratory distress: a model of responses and behaviors to an asphyxial threat for patients who are unable to self-report. Heart Lung. 2008;37(1):54-60.
31. Campbell ML. Psychometric testing of a Respiratory Distress Observation Scale. J Palliat Med. 2008;11(1):44-50.
32. Campbell ML, Templin T, Walch J. A Respiratory Distress Observation Scale for patients unable to self-report dyspnea. J Palliat Med. 2010;13(3):285-290.
33. Campbell ML. How to withdraw mechanical ventilation: a systematic review of the literature. AACN Adv Crit Care. 2007;18(4):397-403.
34. GOLD Expert Panel. Global initiative for chronic obstructive lung disease. http://www.goldcopd.org. Published 2005. Accessed December 22, 2010.
35. Barach AL. Chronic obstructive lung disease: postural relief of dyspnea. Arch Phys Med Rehab. 1974;55:494-504.
36. Sharp J T, Drutz WS, Moisan T, Foster J, Machnach W. Postural relief of dyspnea in severe chronic obstructive lung disease. Am Rev Respir Dis. 1980;122:201-211. (Pubitemid 10087489)
37. Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med. 2004;98(1):66-77. (Pubitemid 38100757)
38. Gallagher R, Roberts D. A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause. J Pain Palliat Care Pharmacother. 2004;18(4):3-15. (Pubitemid 40386073)
39. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010;137(3):674-691.
40. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136:58-61. (Pubitemid 18026433)
41. Jennings AL, Davies AN, Higgins J P, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939-944. (Pubitemid 35316271)
42. Pattinson KTS, Governo RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci. 2009;29:8177-8186.
43. Sironi O, Sbanotto A, Banfi MG, Beltrami C. Midazolam as adjunct therapy to morphine to relieve dyspnea? J Pain Symptom Manage. 2007;33(3):233-234; author reply 234-236. (Pubitemid 46394496)
44. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006;31(1):38-47. (Pubitemid 43143297)
45. Rocker G, Horton R, Currow D, Goodridge D, Young J, Booth S. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax. 2009;64(10):910-915.
46. Kohara H, Ueoka H, Aoe K, et al. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J Pain Symptom Manage. 2003;26(4):962-967. (Pubitemid 37188470)
47. Stone P, Rix, Kurowska A, Tookman. Re: Nebulized furosemide for dyspnea in terminal cancer patients. J Pain Symptom Manage. 2002;24(3):274-275; author reply 275-276.
48. 2 in ventilated quadriplegics. Respir Physiol. 1992;90(1):19-30.